FDA Inspection 1119745 — Supe Heart & Diabetes Hospital And Research Centre
The FDA completed an inspection of Supe Heart & Diabetes Hospital And Research Centre on Nov 8, 2019 in Nashik. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 8, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Nashik (India)
Additional details
Clinical BA/BE